美国研究者 Temes 等的一项研究报告称,已经放置了引流管的脓胸患者,接受胸腔内链激酶(streptokinase)10万～75万 IU,每天1次(n=19)或尿激酶(urokinase)10万～25万 IU,每天1次(n=7)。在给药后立即央住引流管,持续4小时。治疗持续7天,或一直到临床和放射学检测表明病变已消退为止。仅8例患者治疗无效并需要接受手术治疗或留置胸腔引流管>30天。摘自《中国医学论坛报》1997年1月2日7版 A study by American investigator Temes et al. Reported that patients with empyema who had been placed with drainage catheters received 100,000 to 750,000 IU of streptokinase once daily (n = 19) or urokinase ) 100,000 to 250,000 IU once daily (n = 7). Drain the tube immediately after administration for 4 hours. The treatment lasts 7 days or until the clinical and radiological tests show that the lesions have subsided. Only 8 patients were ineffective and required surgery or indwelling chest drainage> 30 days. From “China Medical Tribune” January 2, 1997 7 edition